Sanderling Ventures

Total investments

97

Average round size

19M

Portfolio companies

42

Rounds per year

2.16

Lead investments

15

Follow on index

0.57

Exits

17

Stages of investment
Early Stage VentureLate Stage Venture
Areas of investment
BiotechnologyDrug DiscoveryInformation TechnologyHealth CareGeneticsMedical DeviceMedicalPharmaceuticalTherapeuticsDiabetes

Summary

Sanderling Ventures appeared to be the VC, which was created in 1979. The leading representative office of defined VC is situated in the San Mateo. The venture was found in North America in United States.

The fund has exact preference in some founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight CalciMedica, Metavention, Lineagen. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most successful fund investment fields, there are Genetics, Biopharma.

The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in 2-6 investment rounds annually. Comparing to the other companies, this Sanderling Ventures performs on 14 percentage points less the average number of lead investments. The real fund results show that this VC is 1 percentage points more often commits exit comparing to other companies. The high activity for fund was in 2008. Despite it in 2019 the fund had an activity. The top amount of exits for fund were in 2011. The typical startup value when the investment from Sanderling Ventures is 100-500 millions dollars.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Sanderling Ventures, startups are often financed by Asset Management Ventures (AMV), Qualcomm Ventures, Mesa Verde Venture Partners. The meaningful sponsors for the fund in investment in the same round are Alta Partners, Mayo Clinic Ventures, Asset Management Ventures (AMV). In the next rounds fund is usually obtained by Qualcomm Ventures, Mayo Clinic Ventures, Intel Capital.

The fund was created by Robert McNeil. We also calculated 5 valuable employees in our database.

Show more

Investments analytics

Analytics

Total investments
97
Lead investments
15
Exits
17
Rounds per year
2.16
Follow on index
0.57
Investments by industry
  • Health Care (82)
  • Biotechnology (76)
  • Medical (30)
  • Pharmaceutical (28)
  • Medical Device (24)
  • Show 20 more
Investments by region
  • United States (89)
  • Canada (7)
  • India (1)
Peak activity year
2008
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
20
Avg. valuation at time of investment
42M
Group Appearance index
0.88
Avg. company exit year
13
Avg. multiplicator
1.63
Strategy success index
0.60

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
BioSpace 24 Aug 2000 Health Care, Communities, Medical Early Stage Venture 10M United States, California, San Francisco
ClinBrain 25 Oct 2022 Health Care, Medical, Data Integration Late Stage Venture 30M Shanghai, Shanghai, China
Trinity Biosystems 18 Jul 2006 Biotechnology, Health Care, Therapeutics Early Stage Venture 21M United States, California

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.